LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 77

Search options

  1. Article ; Online: The 4

    Canna, Scott W / De Benedetti, Fabrizio

    Pediatric rheumatology online journal

    2024  Volume 21, Issue Suppl 1, Page(s) 79

    Abstract: Since IL-18 has recently emerged as a biomarker associated with refractory disease course in SJIA, the focus of the discussion was the feasibility of the biomarker-driven drug development to SJIA. Overall, there was broad agreement on the conclusion that ...

    Abstract Since IL-18 has recently emerged as a biomarker associated with refractory disease course in SJIA, the focus of the discussion was the feasibility of the biomarker-driven drug development to SJIA. Overall, there was broad agreement on the conclusion that IL-18 is a uniquely specific biomarker for many of the subsets of SJIA most in need of new therapies, and it may define a class of diseases mediated by IL-18 excess. The consensus was that leveraging IL-18 remains our most promising "lead" for use in refractory SJIA as it may mechanistically explain the disease pathophysiology and lead to more targeted therapies.
    MeSH term(s) Humans ; Arthritis, Juvenile/drug therapy ; Interleukin-18 ; Consensus ; Disease Progression ; Biomarkers
    Chemical Substances Interleukin-18 ; Biomarkers
    Language English
    Publishing date 2024-01-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 2279468-2
    ISSN 1546-0096 ; 1546-0096
    ISSN (online) 1546-0096
    ISSN 1546-0096
    DOI 10.1186/s12969-023-00867-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2.

    Bassiri, Hamid / Canna, Scott W

    The Lancet. Rheumatology

    2022  Volume 4, Issue 5, Page(s) e305–e307

    Language English
    Publishing date 2022-03-29
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(22)00090-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cytokine Storm Syndromes in Pediatric Patients.

    Diorio, Caroline / Teachey, David T / Canna, Scott W

    The journal of allergy and clinical immunology. In practice

    2023  Volume 11, Issue 6, Page(s) 1636–1644

    Abstract: Cytokine storm syndromes (CSS) represent a diverse group of disorders characterized by severe overactivation of the immune system. In the majority of patients, CSS arise from a combination of host factors, including genetic risk and predisposing ... ...

    Abstract Cytokine storm syndromes (CSS) represent a diverse group of disorders characterized by severe overactivation of the immune system. In the majority of patients, CSS arise from a combination of host factors, including genetic risk and predisposing conditions, and acute triggers such as infections. CSS present differently in adults than in children, who are more likely to present with monogenic forms of these disorders. Individual CSS are rare, but in aggregate represent an important cause of severe illness in both children and adults. We present 3 rare, illustrative cases of CSS in pediatric patients that describe the spectrum of CSS.
    MeSH term(s) Humans ; Child ; COVID-19/complications ; SARS-CoV-2 ; Cytokine Release Syndrome ; Cytokines ; Immune System
    Chemical Substances Cytokines
    Language English
    Publishing date 2023-03-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2023.03.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pediatric hemophagocytic lymphohistiocytosis.

    Canna, Scott W / Marsh, Rebecca A

    Blood

    2020  Volume 135, Issue 16, Page(s) 1332–1343

    Abstract: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome describing patients with severe systemic hyperinflammation. Characteristic features include unremitting fever, cytopenias, hepatosplenomegaly, and elevation of typical HLH biomarkers. Patients can ... ...

    Abstract Hemophagocytic lymphohistiocytosis (HLH) is a syndrome describing patients with severe systemic hyperinflammation. Characteristic features include unremitting fever, cytopenias, hepatosplenomegaly, and elevation of typical HLH biomarkers. Patients can develop hepatitis, coagulopathy, liver failure, central nervous system involvement, multiorgan failure, and other manifestations. The syndrome has a high mortality rate. More and more, it is recognized that while HLH can be appropriately used as a broad summary diagnosis, many pediatric patients actually suffer from an expanding spectrum of genetic diseases that can be complicated by the syndrome of HLH. Classic genetic diseases in which HLH is a typical and common manifestation include pathogenic changes in familial HLH genes (PRF1, UNC13D, STXBP2, and STX11), several granule/pigment abnormality genes (RAB27A, LYST, and AP3B1), X-linked lymphoproliferative disease genes (SH2D1A and XIAP), and others such as NLRC4, CDC42, and the Epstein-Barr virus susceptibility diseases. There are many other genetic diseases in which HLH is an infrequent complication of the disorder as opposed to a prominent manifestation of the disease caused directly by the genetic defect, including other primary immune deficiencies and inborn errors of metabolism. HLH can also occur in patients with underlying rheumatologic or autoinflammatory disorders and is usually designated macrophage activation syndrome in those settings. Additionally, HLH can develop in patients during infections or malignancies without a known (or as-yet-identified) genetic predisposition. This article will attempt to summarize current concepts in the pediatric HLH field as well as offer a practical diagnostic and treatment overview.
    MeSH term(s) Animals ; CARD Signaling Adaptor Proteins/genetics ; Calcium-Binding Proteins/genetics ; Child ; Disease Management ; Epstein-Barr Virus Infections/complications ; F-Box-WD Repeat-Containing Protein 7/genetics ; Genetic Predisposition to Disease ; Genetic Variation ; Humans ; Lymphohistiocytosis, Hemophagocytic/diagnosis ; Lymphohistiocytosis, Hemophagocytic/genetics ; Lymphohistiocytosis, Hemophagocytic/physiopathology ; Lymphohistiocytosis, Hemophagocytic/therapy ; Signaling Lymphocytic Activation Molecule Associated Protein/genetics ; X-Linked Inhibitor of Apoptosis Protein/genetics
    Chemical Substances CARD Signaling Adaptor Proteins ; Calcium-Binding Proteins ; F-Box-WD Repeat-Containing Protein 7 ; FBXW7 protein, human ; NLRC4 protein, human ; SH2D1A protein, human ; Signaling Lymphocytic Activation Molecule Associated Protein ; X-Linked Inhibitor of Apoptosis Protein ; XIAP protein, human
    Language English
    Publishing date 2020-02-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2019000936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Should COVID-19 take advice from rheumatologists?

    Kernan, Kate F / Canna, Scott W

    The Lancet. Rheumatology

    2020  Volume 2, Issue 6, Page(s) e310–e311

    Keywords covid19
    Language English
    Publishing date 2020-05-07
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(20)30129-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Highways to hell: Mechanism-based management of cytokine storm syndromes.

    Canna, Scott W / Cron, Randy Q

    The Journal of allergy and clinical immunology

    2020  Volume 146, Issue 5, Page(s) 949–959

    Abstract: Since the first textbook devoted to cytokine storm syndromes (CSSs) was published in 2019, the world has changed dramatically and the term's visibility has broadened. Herein, we define CSSs broadly to include life/organ-threatening systemic inflammation ... ...

    Abstract Since the first textbook devoted to cytokine storm syndromes (CSSs) was published in 2019, the world has changed dramatically and the term's visibility has broadened. Herein, we define CSSs broadly to include life/organ-threatening systemic inflammation and immunopathology regardless of the context in which it occurs, recognizing that the indistinct borders of such a definition limit its utility. Nevertheless, we are focused on the pathomechanisms leading to CSSs, including impairment of granule-mediated cytotoxicity, specific viral infections, excess IL-18, and chimeric antigen receptor T-cell therapy. These mechanisms are often reflected in distinct clinical features, functional tests, and/or biomarker assessments. Moreover, these mechanisms often indicate specific, definitive treatments. This mechanism-focused organization is vital to both advancing the field and understanding the complexities in individual patients. However, increasing evidence suggests that these mechanisms interact and overlap. Likewise, the utility of a broad term such as "cytokine storm" is that it reflects a convergence on a systemic inflammatory phenotype that, regardless of cause or context, may be amenable to "inflammo-stabilization." CSS research must improve our appreciation of its various mechanisms and their interactions and treatments, but it must also identify the signs and interventions that may broadly prevent CSS-induced immunopathology.
    MeSH term(s) Animals ; Cytokine Release Syndrome/diagnosis ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/therapy ; Cytotoxicity, Immunologic ; Humans ; Immunotherapy, Adoptive/adverse effects ; Inflammation ; Interleukin-18/metabolism ; Lymphohistiocytosis, Hemophagocytic ; Macrophage Activation Syndrome ; Virus Diseases/complications ; Virus Diseases/immunology
    Chemical Substances Interleukin-18
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 121011-7
    ISSN 1097-6825 ; 1085-8725 ; 0091-6749
    ISSN (online) 1097-6825 ; 1085-8725
    ISSN 0091-6749
    DOI 10.1016/j.jaci.2020.09.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.

    Landy, Emily / Varghese, Jemy / Dang, Vinh / Szymczak-Workman, Andrea / Kane, Lawrence P / Canna, Scott W

    Blood advances

    2023  Volume 7, Issue 22, Page(s) 6949–6963

    Abstract: Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening hyperinflammatory syndromes. Familial HLH is caused by genetic impairment of granule-mediated cytotoxicity (eg, perforin deficiency). MAS is linked to ... ...

    Abstract Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening hyperinflammatory syndromes. Familial HLH is caused by genetic impairment of granule-mediated cytotoxicity (eg, perforin deficiency). MAS is linked to excess activity of the inflammasome-activated cytokine interleukin-18 (IL-18). Though individually tolerated, mice with dual susceptibility (Prf1⁻/⁻Il18tg; DS) succumb to spontaneous, lethal hyperinflammation. We hypothesized that understanding how these susceptibility factors synergize would uncover key pathomechanisms in the activation, function, and persistence of hyperactivated CD8 T cells. In IL-18 transgenic (Il18tg) mice, IL-18 effects on CD8 T cells drove MAS after a viral (lymphocytic choriomeningitis virus), but not innate (toll like receptor 9), trigger. In vitro, CD8 T cells also required T-cell receptor (TCR) stimulation to fully respond to IL-18. IL-18 induced but perforin deficiency impaired immunoregulatory restimulation-induced cell death (RICD). Paralleling hyperinflammation, DS mice displayed massive postthymic oligoclonal CD8 T-cell hyperactivation in their spleens, livers, and bone marrow as early as 3 weeks. These cells increased proliferation and interferon gamma production, which contrasted with increased expression of receptors and transcription factors associated with exhaustion. Broad-spectrum antibiotics and antiretrovirals failed to ameliorate the disease. Attempting to genetically "fix" TCR antigen-specificity instead demonstrated the persistence of spontaneous HLH and hyperactivation, chiefly on T cells that had evaded TCR fixation. Thus, drivers of HLH may preferentially act on CD8 T cells: IL-18 amplifies activation and demand for RICD, whereas perforin supplies critical immunoregulation. Together, these factors promote a terminal CD8 T-cell activation state, combining features of exhaustion and effector function. Therefore, susceptibility to hyperinflammation may converge on a unique, unrelenting, and antigen-dependent state of CD8 T-cell hyperactivation.
    MeSH term(s) Mice ; Animals ; Lymphohistiocytosis, Hemophagocytic/etiology ; Perforin/genetics ; Perforin/metabolism ; Interleukin-18/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Receptors, Antigen, T-Cell/metabolism
    Chemical Substances Perforin (126465-35-8) ; Interleukin-18 ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2023-09-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2023010502
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease?

    Canna, Scott W

    Arthritis & rheumatology (Hoboken, N.J.)

    2014  Volume 66, Issue 5, Page(s) 1072–1076

    MeSH term(s) Animals ; Arthritis, Juvenile/chemically induced ; Arthritis, Juvenile/physiopathology ; Disease Models, Animal ; Female ; Freund's Adjuvant/adverse effects ; Immune System/physiopathology ; Interferon-gamma/deficiency ; Interferon-gamma/physiology ; Male
    Chemical Substances Interferon-gamma (82115-62-6) ; Freund's Adjuvant (9007-81-2)
    Language English
    Publishing date 2014-01-27
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.38362
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Should COVID-19 take advice from rheumatologists?

    Kernan, Kate F / Canna, Scott W

    The Lancet Rheumatology

    2020  Volume 2, Issue 6, Page(s) e310–e311

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2665-9913
    DOI 10.1016/s2665-9913(20)30129-6
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top